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Background: Castleman’s disease is a rare disease characterized by lymph node hyperplasia. Its occurrence in the
retroperitoneal space has rarely been reported, making its preoperative diagnosis difficult. Here, we report a case of
retroperitoneal Castleman’s disease, which radiologically resembled paraspinal schwannoma.
Case presentation: A 33-year-old Japanese man with epigastric discomfort underwent abdominal ultrasonic
examination revealing a solid mass next to the right kidney. Computed tomography demonstrated a well-
circumscribed mass with central calcification in the right psoas muscle. Because the mass presented a dumbbell-like
shape extending to the intervertebral foramen, neurogenic tumor was suspected. Both iodine-123
metaiodobenzylguanidine and gallium-67 scintigraphies were negative in the mass, whereas thallium-201 mildly
accumulated in the tumor, suggesting blood flow to the tumor. Positron emission tomography revealed
accumulation of fluorine-18-2-fluoro-2-deoxy-D-glucose in the tumor at a standard uptake value of 4.7, whereas no
other abnormal uptake suggestive of metastatic lesion was noted. On the basis of imaging studies, we mostly
suspected paraspinal schwannoma, although malignancy was not completely excluded. Angiography showed
feeding vessels from the right lumbar arteries, which were embolized with porous gelatin particles in order to
reduce intraoperative bleeding. Surgical resection was performed using a retroperitoneal approach, which revealed
the tumor in the swollen psoas muscle. Intraoperative pathological examination of a frozen section revealed no
evidence of malignancy; thus, marginal excision of the tumor was performed. The tumor adhered tightly to
surrounding muscle tissues, resulting in 940 g of intraoperative blood loss. The pathological examination
demonstrated infiltration of lymphocytes surrounding small germinal centers with extensive capillary proliferation.
Immunostaining revealed that proliferated lymphocytes were CD3-negative and CD79a-positive.
Conclusions: Although a dumbbell-shaped mass in a paraspinal region is indicative of a schwannoma for
orthopedic surgeons, the possibility of Castleman’s disease should be considered if a central low-signal area in
fissured and a radial pattern is detected on computed tomography or magnetic resonance imaging. Appropriate
preparation for massive bleeding during the treatment of Castleman’s disease, including angiography and
embolization, would be helpful for performing surgical procedures safely.
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Castleman’s disease (CD) is a rare disease characterized
by lymph node hyperplasia with polyclonal proliferation,
first reported by Castleman in 1954 [1]. CD is classified
into unicentric CD (UCD) and multicentric CD (MCD)
affecting a single lymphatic organ and multiple sites
throughout the body, respectively [2,3]. Although MCD
is less common, it accompanies systemic chronic inflam-
matory symptoms induced by interleukin (IL)-6 from af-
fected lymph nodes [3]. MCD carries a worse prognosis,
although IL-6 blockade by the recently approved
tocilizumab is a promising treatment option [4]. On the
other hand, UCD usually involves benign manifestations
and can be cured by surgical excision. Although the
most common site of UCD is the mediastinum (70%)
[5], it may occur anywhere along the lymphatic chain.
UCD in the retroperitoneal space is relatively rare, ac-
counting for 6.5–8.2% of all UCD cases [6]. Because of
its rarity, the preoperative diagnosis of retroperitoneal
UCD is very difficult [7]. Here, we report on a case of
retroperitoneal UCD, which resembled radiologically
paraspinal schwannoma.A
C D
Figure 1 Plain radiography and computed tomography. A striated calc
was noted (arrow) in abdominal plain radiography (A,B). Computed tomog
in the swollen psoas muscle (C). After contrast enhancement, the mass presCase presentation
A 33-year-old man with epigastric discomfort underwent
abdominal ultrasonic examination, revealing a solid mass
next to the right kidney. Abdominal radiography revealed
striated calcification on the right side of the first and second
lumbar vertebrates (Figure 1A,B). Computed tomography
(CT) demonstrated a well-circumscribed, homogenous
mass with central calcification in the right psoas muscle
(Figure 1C). Characteristically, the mass presented in
a dumbbell-like shape, extending to the intervertebral
foramen on contrast-enhanced CT (Figure 1D). On the
basis of the characteristic shape, a neurogenic tumor was
suspected. Magnetic resonance imaging (MRI) revealed an
isointense mass on the T1-weighted image (T1WI) and a
hyperintense mass on the T2-weighted image (T2WI) with
a central radial hypointense area (Figure 2A,B). On the
caudal and anterior side of the tumor, a lipomatous com-
ponent was observed (Figure 2B,C). Contrast-enhanced
axial T1WI showed marked enhancement of the tumor
(Figure 2D). Both iodine-123 metaiodobenzylguanidine
and gallium-67 scintigraphies were negative in the mass,
suggesting pheochromocytoma and lymphoma as lessB
ification on the right side of the first and second lumbar vertebrates
raphy revealed a homogenous mass with central calcification (arrow)
ented a dumbbell-like shape, extending to the intervertebral foramen (D).
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Figure 2 Magnetic resonance imaging. The mass presented isointensity on the T1-weighted image (A) and hyperintensity on the T2-weighted
image (B) with a central radial hypointense area. On the caudal and anterior side of the tumor, a lipomatous component was observed on T2-weighted
images (B,C). The contrast-enhanced image showed marked enhancement of the tumor (D).
Nagano et al. World Journal of Surgical Oncology 2013, 11:108 Page 3 of 7
http://www.wjso.com/content/11/1/108susceptive diagnoses (Figure 3A,B). Thallium-201 mildly
accumulated in the tumor, suggesting blood flow to the
tumor (Figure 3C). Positron emission tomography (PET)
revealed accumulation of fluorine-18-2-fluoro-2-deoxy-D-
glucose in the tumor at a standard uptake value (SUV) of
4.7, whereas no other abnormal uptake suggestive of a
metastatic lesion was demonstrated (Figure 3D). On the
basis of all imaging findings, preoperative differential diag-
noses included schwannoma, inflammatory myofibro-
blastic tumor, and liposarcoma. Because significant blood
flow to the tumor was suspected, angiography was
performed on the day prior to surgery revealing abundant
vascularity (Figure 3E). Feeding vessels from the right
lumbar arteries were embolized with porous gelatin parti-
cles (Gelpart, Nihon-Kayaku, Tokyo, Japan) in order to
reduce intraoperative bleeding (Figure 3F).
Surgical resection was performed with the retroperi-
toneal approach from the right side by resecting the 11th
rib (Figure 4A). The tumor existed in the swollen psoas
muscle, accompanying multiple feeding vessels around
the tumor (Figure 4B). Before excision, a small piece of
tumor tissue was submitted for intraoperative patho-
logical examination by frozen section. The pathological
examination was suggestive of inflammatory myofibro-
blastic tumor, and no evidence of malignancy was noted.
We decided to perform marginal excision of the tumor.
After ligation and transection of several feeding vessels,
we carefully dissected the tumor that adhered tightly to
surrounding muscle tissues. The total blood loss was
940 g and the patient recovered without any postsurgicalcomplication. The tumor was an encapsulated, tan, elas-
tic soft oval mass sized 11 × 8 × 8 cm (Figure 4C). The
cut surface was dark red with a central white zone of
fibrosis and calcification (Figure 4D).
Pathological examination demonstrated infiltration of
lymphocytes forming lymphoid follicles accompanied with
capillary proliferation (Figure 5A). Capillaries were sur-
rounded by hyaline sheaths (Figure 5B). Immunostaining
revealed that the proliferated lymphocytes were positive
for the B-cell marker CD79a and negative for the T-cell
marker CD3 (Figure 5C). In general, abundant IgG4-
positive plasma cells are observed in plasma cell type CD,
whereas hyaline-vascular type CD is accompanied only by
a few IgG4-positive plasma cells [8]. IgG4-positive cells
were very sparsely observed in the present case, ruling out
plasma cell type CD. The diagnosis of hyaline-vascular
type UCD (HV-UCD) was established.There was no sign
of recurrence at 1 year after surgery.
Discussion
A recent meta-analysis of retroperitoneal tumors showed
that sarcoma comprise a third of retroperitoneal tumors
[9]. A variety of neoplasms could occur in the retroperi-
toneal space, including liposarcoma, lymphoma, epithelial
tumors, or metastatic disease from known or unknown
primary sites. Benign retroperitoneal tumors include be-
nign neurogenic tumors, paragangliomas, fibromatosis,
renal angiomyolipomas, and benign retroperitoneal lip-
omas. Because of the late presentation of symptoms, tu-
mors have often reached a significant size. Therefore,
A B C D
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Figure 3 Radionuclide imaging and angiography. Both iodine-123 metaiodobenzylguanidine (A) and gallium-67 (B) scintigraphies were
negative in the mass, whereas thallium-201 mildly accumulated in the tumor below the right kidney (C, arrow). Positron emission tomography
was positive in the tumor at a standard uptake value of 4.7 without any other abnormal uptake in other parts of the body (D). Digital subtraction
angiography revealed abundant vascularity of the tumor (E, arrow). Feeding vessels from the right lumbar arteries were embolized with porous
gelatin particles (F).
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recurrence associated with a less favorable outcome. A
preoperative diagnosis is important in order to plan the
surgical procedure and adjuvant treatment. However, be-
cause of the rarity of the disease, a preoperative diagnosis
of UCD was not made in previous case reports of UCD
[10,11], resulting in the surgical exploration of suspicious
malignant tumors, including liposarcomas [12], malignant
fibrous histiocytomas [7], vascular sarcomas [13], and ad-
renal neoplasms [14]. Retroperitoneal schwannoma is also
rare, but anatomical proximity to adjacent neural struc-
tures in imaging studies should raise suspicion [15]. In the
present case, the tumor was located in the psoas muscle,
and the medial edge of the tumor extended towards the
lumbar intervertebral foramen as demonstrated by CT
and MRI (Figures 1 and 2) suggesting schwannoma as pri-
mary suspicious diagnosis. A characteristic imaging find-
ing of schwannoma is the target sign, which histologically
corresponds to peripheral myxomatous tissue and central
collagenous tissue [16]. The present case also showed the
target-like pattern in T2WI of MRI, surrounded by fat
tissue (Figure 2B). The central area of low intensityhistologically corresponded to fibrous tissue (Figure 5),
which could be found in abdominal CD. However, Zhou
et al. reported that a central area of low-density on CT
and low-intensity on MRI showed a fissured and radial
pattern [17], which was found in our case. Therefore, the
presence of the target sign on MRI as well as the shape of
the central low-intensity area may help to distinguish CD
from schwannoma.
Because the findings by CT and MRI did not lead to a
definite preoperative diagnosis, radionuclide studies,
including PET, were performed. Negativity of gallium
scintigraphy suggested malignant lymphoma as a less
suspected diagnosis. It is reasonable that CD could be
positive for gallium scintigraphy because of its nature of
lymphatic proliferative disease [18]. However, its positivity
would depend on the inflammatory activity of an indivi-
dual case, which explains why the present case was nega-
tive for gallium-67. PET recently became a common
modality for the diagnosis and evaluation of therapeutic ef-
fects on malignant tumors. A recent study revealed that the
median SUV of seven patients with active MCD was 4.8






Figure 4 Intraoperative gross findings. Tumor resection was performed with the retroperitoneal approach from the right side by resecting the
11th rib (A,B). The tumor existed in the swollen psoas muscle (*), adjacent to the posterior-distal edge of the pleural cavity (B, #). The tumor was
an encapsulated, tan, elastic soft oval mass sized 11 × 8 × 8 cm (C). The cut surface was dark red with a central white zone of fibrosis and
calcification (D).
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nature of CD may lead to high SUV, making it difficult
to exclude malignant tumor before biopsy. Oida et al.
reported a case of UCD that showed an SUV of 4.5 in
the PET study, resulting in its incorrect preoperative
diagnosis as lymphoma [20]. Therefore, even with the
most advanced imaging techniques, including PET, the
preoperative diagnosis of retroperitoneal tumors, includ-
ing CD, still seems difficult [2].
HV-UCD is the most common variant of CD and ac-
counts for 72% of all CD variants [3]. Plasma cell type CD500µm
A B
Figure 5 Pathological findings. Lymphocytes formed lymphoid follicles a
by hyaline sheaths (B). Immunostaining revealed that the proliferated lymp
CD of hyaline-vascular type was established.(PC-UCD) displays of mature plasma cell proliferation in
the areas surrounding the germinal centers, without
accompanyinghyalinized vessel formation [3,8]. PC-UCD
and PC-MCD account for 18% and 10% of all PC variants,
respectively. The treatment differs by the type of CD,
reflecting the clinical behavior of each variant. Both HV-
UCD and PC-UCD can be cured by complete resection of
the affected lymph node; recurrence, metastasis, or mor-
tality have not been reported [2,3,21]. Rare cases of PC-
UCD show remnant systemic symptoms after resection;
however, additional therapy for those PC-UCD cases is200µm
C
200µm
nd capillary proliferation was observed (A). Capillaries were surrounded
hocytes were positive for the B-cell marker CD79a (C). The diagnosis of
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ment option for cases of surgically unresectable UCD
[2,21]. Cure can be achieved by radiotherapy in selected
patients with UCD, although its role in UCD treatment
remains unclear [21]. Regarding the follow-up for UCD,
patients without systemic involvement should have an
additional radiological assessment 6–12 months postoper-
atively to verify the cure; additional testing or therapy
should be considered at the onset of new symptoms [10].
Surgeons should be prepared for massive bleeding du-
ring the resection of CD, especially in the deep portion
of the body close to major vessels. Preoperative angiog-
raphy clearly visualized the feeding vessels that aided
intraoperative detection and ligation of the feeding lum-
bar artery. If such an imaging study is not performed
and the preoperative diagnosis does not include such
hemorrhagic tumors, massive bleeding may obstruct sur-
gical procedures and patients may be at risk of fatal blood
loss. Although we chose the retroperitoneal approach
in the decubitus position in the present case, the
transperitoneal approach may have been an alternative op-
tion for tumor resection. One of the reasons for us choos-
ing this is approach is familiarity with the retroperitoneal
approach for spinal surgery. Another reason is that explor-
ation of the intervertebral foramen may have been re-
quired because schwannoma was the most suspected
preoperative diagnosis. If UCD is preoperatively suspected
and the surgeons are familiar with the transperitoneal
approach, the wide operative field obtained with that
approach may be helpful to reduce intraoperative bleeding.
Conclusions
The paraspinal mass that resembled a schwannoma
proved to be a rare case of UCD. Careful preoperative
assessment of the imaging study enables proper planning
of the surgery. More importantly, central low areas in
fissured and radial pattern on CT or MRI would be
helpful for making the correct diagnosis of CD.
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